Clinical trials
Recurrent Bacterial Vaginosis clinical trials
Below are recruiting recurrent bacterial vaginosis clinical trials, each written for real people, not researchers. We’re tracking 6 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06725888Recruiting
Vagitab-T for bacterial vaginosis
This study tests a medical device called Vagitab-T as an extra treatment for women with bacterial vaginosis who are already taking the antibiotic metronidazole. It may help prevent the infection from coming back.
Timișoara, Timiș CountyAges 18–65 - NCT07514416RecruitingPhase 1
Safety study of LCFA-01 drug in healthy women
This study tests a new drug called LCFA-01 to make sure it's safe and works as expected in healthy women. The drug is being developed to treat bacterial vaginosis, a common vaginal infection.
Brisbane, QueenslandAges 18–40 - NCT04046900RecruitingPhase 1/Phase 2
Fecal-style transplant of vaginal microbiome for recurring BV
This trial tests whether transplanting “good bacteria” into the vagina can treat recurrent bacterial vaginosis (BV). It may help restore a healthier vaginal bacterial balance and reduce BV episodes.
Boston, MassachusettsAges 18–50 - NCT05963711Recruiting
Study penis microbiome in partners during vaginal microbiome treatment
This study looks at how the bacteria on a man’s penis may change during a woman’s vaginal microbiome transplant (VMT) for recurrent bacterial vaginosis (BV). You may be asked to follow condom and “decolonization” steps to help the researchers understand what works and why.
JerusalemAges 18 years+ - NCT05753813RecruitingEarly Phase 1
Study lactic acid gel to change vaginal germs
This early study tests whether placing a lactic acid gel inside the vagina can change the vaginal “microbiome,” the mix of germs, to help reduce repeat BV or yeast infections. You may join if you’ve had at least two recent episodes that needed treatment.
Honolulu, HawaiiAges 18–54 - NCT01829204Recruiting
Health study registry for vaginal conditions
This study is building a database (a secure record) to learn about vaginal/vulva conditions in women. You may be invited if you’re coming in for a routine women’s health visit or you’re being seen for a vaginal concern, and you can share information safely.
Midland, TexasAges 21–75
Hear when a new Recurrent Bacterial Vaginosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for recurrent bacterial vaginosis?
- Yes. Clin2 currently lists 6 recruiting recurrent bacterial vaginosis studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a recurrent bacterial vaginosis trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a recurrent bacterial vaginosis trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.